Atara Biotherapeutics, Inc. short interest in 2026
In 2026, Atara Biotherapeutics, Inc.'s disclosed short interest ran from 3.92% of shares outstanding on 30 Jan 2026 to 4.03% on 15 Sep 2026, a change of +0.11 percentage points. The year's high was 7.06% on 15 Jul 2026 and its low 2.90% on 13 Feb 2026, averaging 4.79% across 16 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.07 days on 31 Aug 2026. Full history: Atara Biotherapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2026 in figures
- Start of year
- 3.92% (30 Jan 2026)
- End of year
- 4.03% (15 Sep 2026)
- Change
- +0.11 pp
- High
- 7.06% (15 Jul 2026)
- Low
- 2.90% (13 Feb 2026)
- Average
- 4.79%
- Highest days to cover
- 11.07 (31 Aug 2026)
- SEC filings marked
- 6
Every report in 2026
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 30 Jan 2026 | 3.92% | 1.00 | results (8-K) |
| 13 Feb 2026 | 2.90% | 2.40 | |
| 27 Feb 2026 | 4.58% | 2.13 | |
| 13 Mar 2026 | 3.83% | 1.00 | |
| 31 Mar 2026 | 4.00% | 3.01 | 10-K filed, results (8-K) |
| 15 Apr 2026 | 3.89% | 4.10 | |
| 30 Apr 2026 | 3.74% | 6.10 | |
| 15 May 2026 | 6.68% | 1.00 | 10-Q filed |
| 29 May 2026 | 5.92% | 2.91 | |
| 15 Jun 2026 | 6.02% | 6.27 | |
| 30 Jun 2026 | 4.42% | 3.95 | |
| 15 Jul 2026 | 7.06% | 6.24 | |
| 31 Jul 2026 | 6.57% | 9.39 | |
| 14 Aug 2026 | 4.75% | 9.21 | 10-Q filed, results (8-K) |
| 31 Aug 2026 | 4.26% | 11.07 | |
| 15 Sep 2026 | 4.03% | 7.34 |
See also: Atara Biotherapeutics, Inc.'s full history · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.